SNDX R&D Expenses
Syndax Pharmaceuticals Inc · R&D Expenses
SNDX R&D Expenses
Latest reported$68.04Mperiod ending
SNDX Quarterly R&D Expenses ($544.00 → $68.04M)
Quarterly R&D Expenses
High-resolution chart · PNG
SNDX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 68,036,000 | |
| 58,845,000 | |
| 78,641,000 | |
| 56,280,000 | |
| 62,227,000 | |
| 61,636,000 | |
| 65,529,000 | |
| 70,971,000 | |
| 48,655,000 | |
| 56,492,000 | |
| 55,126,000 | |
| 39,087,000 | |
| 34,764,000 | |
| 34,054,000 | |
| 31,841,000 | |
| 26,901,000 | |
| 29,734,000 | |
| 30,022,000 | |
| 23,900,000 | |
| 25,606,000 | |
| 16,871,000 | |
| 21,870,000 | |
| 15,522,000 | |
| 14,408,000 | |
| 10,943,000 | |
| 9,562,000 | |
| 9,502,000 | |
| 9,923,000 | |
| 12,290,000 | |
| 11,279,000 | |
| 15,821,000 | |
| 14,095,000 | |
| 14,851,000 | |
| 15,339,000 | |
| 16,599,000 | |
| 12,188,000 | |
| 9,862,000 | |
| 9,552,000 | |
| 8,474,000 | |
| 12,274,000 | |
| 6,131,000 | |
| 4,786,000 | |
| 2,587,000 | |
| 2,968,000 | |
| 2,271,000 | |
| 1,723,000 | |
| 1,455,000 | |
| 1,709,000 | |
| 4,874,000 | |
| 2,137,000 | |
| 1,059,000 | |
| 845,000 | |
| 731,000 | |
| 573,000 | |
| 544 |